Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition
Oncology Research · 2026
DOI: 10.32604/or.2026.084576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Jiang-Nan Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Triple Negative Breast Neoplasms, Neoplastic Stem Cells. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Xia, J. N., Zhu, S. D., Qu, W. L., Hu, Y. L., Ma, W. Y., Wang, W., Huang, Q. L., Lin, B. Y., Guo, J. E., & Li, Y. W. (2026). Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition. Oncology Research. https://doi.org/10.32604/or.2026.084576
Vancouver
Xia JN, Zhu SD, Qu WL, Hu YL, Ma WY, Wang W, et al. Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition. Oncology Research. 2026. doi:10.32604/or.2026.084576
BibTeX
@article{Xia2026,
author = {Xia, Jiang-Nan and Zhu, Shan-Dong and Qu, Wei-Ling and Hu, Yi-Lin and Ma, Wen-Yi and Wang, Wenyan and Huang, Qian-Lan and Lin, Bing-Yuan and Guo, Jia-En and Li, Ying-Wei},
title = {Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.084576}
}
EUVIMED